Differential distribution and biochemical characteristics of hydrolases among developmental stages of Schistosoma mansoni may offer new anti-parasite targets.

Schistosoma mansoni enzymes play important roles in host-parasite interactions and are potential targets for immunological and/or pharmacological attack. The aim of this study was to comparatively assess the presence of hydrolytic activities (phosphatases, glycosidases, aminopeptidases) in soluble (SF) and membrane (MF) fractions from different S. mansoni developmental stages (schistosomula 0 and 3h, juveniles, and adult worms of 28 and 45days-old, respectively), by using simple enzyme-substrate microassays. Our results show and confirm the prominent presence of alkaline phosphatase (AlP) activity in the MF of all the above parasite stages, highlighting also the relevant presence of MF-associated α-mannosidase (α-MAN) activity in juveniles. A soluble AlP activity, together with ß-N-D-acetylglucosaminidase (ß-NAG), and α-MAN activities, was detected in SF of schistosomulum 0h. Soluble ß-NAG, α-MAN, acid phosphatase (AcP), leucin (LAP) and alanine (AAP) aminopeptidase activities were also seen in the SF of the other different developmental stages. This work shows different soluble and membrane-associated hydrolytic capacities in each S. mansoni developmental stage from schistosomula to adults that might be exploitable as potential new targets for immune and/or chemoprophylactic strategies.

Immunocapture of circulating Schistosoma mansoni cathepsin B antigen (Sm31) by anti-Sm31 polyclonal antibodies.

Adult Schistosoma mansoni parasites have the capacity to degrade ingested host hemoglobin and other host plasma proteins by using a series of gut proteolytic enzymes, including cathepsin B; this enzyme is released to the host intravascular environment during regurgitations of adult worms. Cathepsin B becomes thus a circulating parasite component that has been shown to be specifically recognized as the Sm31 antigen by antibodies present in most S. mansoni infected patients. Taking advantage of this immunological property, we attempted here to immunocapture Sm31 from sera of infected patients using specific polyclonal rabbit antibodies raised against a highly enriched preparation of Sm31 and detect its intrinsic proteolytic activity using a previously described solid-phase procedure called Cysteine Protease Immuno Assay (CPIA). To produce highly specific anti-Sm31/cathepsin B antibodies, cathepsin B (Sm31 or SmCB) was enriched more than 3000-folds from an adult worm preparation using a series of conventional biochemical steps including ion exchange and affinity chromatography. Anti-cathepsin B antibodies were generated by immunizing rabbits with the enriched cathepsin B fraction; these antibodies recognized a band of Mr.~31 kDa in Western-blot (WB) analysis of this fraction and were able to capture, in a modified CPIA procedure, Sm31/SmCB present in sera from infected Venezuelan patients living in low endemic areas for schistosomiasis. CPIA showed 100% sensitivity and 100% specificity; representing a new diagnostic tool to detect circulating Sm31 antigen in actual infections.

nzimas y glicoproteínas presentes en extractos de vermes adultos de Fasciola hepatica / Enzymes and glycoproteins present in extracts of adult Fasciola hepatica worms

Fasciola hepatica es un trematodo que causa lesiones en el hígado y vías biliares afectando a herbívoros y al hombre, constituyendo un problema de salud pública en zonas agrícolas a nivel mundial. El parásito posee glicoproteínas y enzimas que facilitan su penetración y migración en los tejidos hospederos. El objetivo fue evaluar estos componentes en extractos [fracción soluble (FS) y fracción particulada (FP)] de vermes adultos de F. hepatica. Las fracciones fueron analizadas para proteínas, carbohidratos, actividades enzimáticas, y por electroforesis (SDS-PAGE-15%) en condiciones no reductoras (NR) y reductoras (R). En FS, la concentración de carbohidratos fue 5,63 μmol/mL; se detectó la presencia de fosfohidrolasas, glicosidasas y peptidasas, sobresaliendo la actividad Fosfatasa Acida (1,19 μmol/h/mg, pH 5,0). En FP, la concentración de carbohidratos fue más elevada (7,89 μmol/mL); se observaron valores elevados de Fosfatasa Alcalina (5,79 μmol/h/mg), Fosfatasa Acida (1,67 μmol/h/mg) y moderados de Fosfodiesterasa (0,280 μmol/h/mg pH 9,6). Se detectó actividad Acetilcolinesterasa mayor en FS que en FP (3,95 A/h vs. 1,68 A/h). En SDS-PAGE ambos extractos mostraron polipéptidos de ~80 a 10-kDa; el pre-tratamiento de las muestras con sodio-metaperiodato redujo el número de bandas en cada extracto, sugiriendo la presencia de glicocomponentes. En conclusión, se hallaron enzimas y glicocomponentes en los extractos de F. hepatica estudiados, lo cual constituye un aporte en la búsqueda de posibles blancos inmunológicos y farmacológicos para el control de esta parasitosis.

Fasciola hepatica is a trematode that causes damage to the liver and biliary tract in both herbivores and man, and is thus an important public health concern in agricultural areas worldwide. This parasite contains glycoproteins and enzymes that facilitate its penetration of, and migration through, host tissues. The aim of this study was to evaluate the relative proportions of these components in the soluble fraction (SF) and n-butanol-solubilized extracts of the particulate fraction (PF) of whole homogenates of adult F. hepatica worms. Extracts were analyzed for protein and carbohydrate content, and hydrolytic activity. In addition, 15% SDS-PAGE electrophoresis was performed under non-reducing (NR) and reducing (R) conditions to identify other components. The SF contained 5.63 μmol carbohydrate/mL, as well as phosphohydrolases, glycosidases and peptidases, with a high acid phosphatase activity (1.19 μmol/h/mg, pH 5.0) that seemed to be characteristic of this fraction. The PF contained 7.89 μmol carbohydrate/mL, with high alkaline phosphatase (5.79 μmol/h/mg) and acid phosphatase (1.67 μmol/h/mg), and moderate phosphodiesterase (0.280 μmol/h/mg pH 9.6) values. Acetylcholinesterase activity was higher in the SF than the PF (3.95 A/h vs. 1.68 A/h). SDS-PAGE analysis showed the presence of polypeptides in both the SF and the PF of ~80 to 10-kDa . Pretreatment with sodium-metaperiodate reduced the number of bands in each extract suggesting the presence of glycocomponents. The notable presence of enzymes and glycocomponents in the SF and PF extracts of adult F. hepatica worms is a first step towards the eventual identification of new immunological and pharmacological targets for the control of this disease.

Long-term effect of mass chemotherapy, transmission and risk factors for Schistosoma mansoni infection in very low endemic communities of Venezuela.

The prevalence of Schistosoma mansoni infection in Venezuela has changed from high to low due mostly to successful control activities, including mass chemotherapy and molluscicide applications. This study examined the impact of mass chemotherapy on S. mansoni transmission and risk factors for infection 12 years after administration of praziquantel in Venezuela. Two relatively isolated rural communities were studied, one with snail control (Manuare) and the second without (Los Naranjos). A cross-sectional survey of randomly selected households included 226 (Manuare) and 192 (Los Naranjos) consenting participants. S. mansoni prevalence was determined using a combination of coprological (Kato-Katz) and serological (circumoval precipitin test, alkaline phosphatase immunoassay and Western blot) tests. Data on epidemiological and socioeconomic risk factors were obtained through individual structured interviews. Univariate analysis and multivariate logistic regression models identified independent risk factors for infection. Water sites were examined for the presence of Biomphalaria glabrata snails. Only one participant was positive by coprology. The overall prevalences according to the combined tests were 32.7% in Manuare and 26.6% in Los Naranjos. Lower prevalences (12.7% in Manuare and 13.2% in Los Naranjos) were found in children <12 years of age representing those born after mass chemotherapy. Social demographic variables associated with infection in both communities were older age (>25 years), contact with specific water sites, and being a farmer/non-specialised worker. Mass treatment with praziquantel applied once to endemic communities led to an important and long-lasting sustained reduction of S. mansoni infections independent of the application of snail control. A degree of low active transmission of S. mansoni persisted in the treated areas which was associated with similar factors in both communities.

Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.

BACKGROUND: Schistosomiasis continues to be one of the most prevalent parasitic diseases in the world. Despite the existence of a highly effective antischistosome drug, the disease is spreading into new areas, and national control programs do not arrive to complete their tasks particularly in low endemic areas. The availability of a vaccine could represent an additional component to chemotherapy. Experimental vaccination studies are however necessary to identify parasite molecules that would serve as vaccine candidates. In the present work, C57BL/6 female mice were subcutaneously immunized with an n-butanol extract of the adult worm particulate membranous fraction (AWBE) and its protective effect against a S. mansoni challenge infection was evaluated. METHODOLOGY AND FINDINGS: Water-saturated n-butanol release into the aqueous phase a set of membrane-associated (glyco)proteins that are variably recognized by antibodies in schistosome-infected patients; among the previously identified AWBE antigens there is Alkaline Phosphatase (SmAP) which has been associated with resistance to the infection in mice. As compared to control, a significantly lower number of perfuse parasites was obtained in the immunized/challenged mouse group (P<0.05, t test); and consequently, a lower number of eggs and granulomas (with reduced sizes), overall decreasing pathology. Immunized mice produced high levels of sera anti-AWBE IgG recognizing antigens of ∼190-, 130-, 98-, 47-, 28-23, 14-, and 9-kDa. The ∼130-kDa band (the AP dimer) exhibited in situ SmAP activity after addition of AP substrate and the activity was not apparently inhibited by host antibodies. A preliminary proteomic analysis of the 25-, 27-, and 28-kDa bands in the immunodominant 28-23 kDa region suggested that they are composed of actin. CONCLUSIONS: Immunization with AWBE induced the production of specific antibodies to various adult worm membrane molecules (including AP) and a partial (43%) protection against a challenging S. mansoni infection by mechanism(s) that still has to be elucidated.

Immunoblot analysis of membrane antigens of Schistosoma mansoni, Schistosoma intercalatum, and Schistosoma haematobium against Schistosoma-infected patient sera.

Antigens present in aqueous n-butanolic extracts (BE) of Schistosoma mansoni (Venezuelan JL strain), Schistosoma intercalatum (Cameroon EDEA strain), and Schistosoma haematobium (Yemen strain) adult worm membranes were compared in immunoblot against sera of patients infected with S. mansoni, S. intercalatum, S. haematobium, Schistosoma japonicum, or Schistosoma mekongi looking for similarities (common antigens) and differences (species-specific antigens). About 17 S. mansoni BE polypeptides (M (r) approximately 8 to >80 kDa) were commonly recognized by S. mansoni-infected patient sera from Venezuela, Senegal, and Ethiopia. S. intercalatum-, S. haematobium-, or S. japonicum-infected sera were almost unreactive with S. mansoni BE. Nonetheless, S. mekongi-infected sera weakly cross-reacted with a approximately 10-15-kDa subset of S. mansoni BE. About 72.7% of S. intercalatum-infected patient sera reacted with a approximately 19-21-kDa complex in S. intercalatum BE and cross-reacted with a similar complex in S. haematobium BE. Conversely, all S. haematobium-infected patient sera reacted with a approximately 19-21-kDa complex in S. haematobium BE and cross-reacted with the approximately 19-21-kDa complex in S. intercalatum BE; S. mansoni- and S. japonicum-infected patient sera did not react with S. intercalatum or S. haematobium BE. Results showed the presence of a common membrane antigen between African schistosome species and species-specific antigens in S. mansoni BE that could be useful to discriminate between species and/or to detect Schistosoma infections.

Detection of Schistosoma mansoni membrane antigens by immunoblot analysis of sera of patients from low-transmission areas.

Schistosoma mansoni surface membrane components play a relevant role in the host-parasite interaction, and some are released in vivo as circulating antigens. n-Butanol extraction favors the release of membrane antigens like alkaline phosphatase, which has been shown to be specifically recognized by antibodies from S. mansoni-infected humans and animals. In the present study, components in the n-butanol extract (BE) of the adult S. mansoni worm membrane fraction were separated by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (1D SDS-PAGE [15%]) and further analyzed by immunoblotting (immunoglobulin G) using defined sera. S. mansoni-infected patient sera, but not sera of uninfected patients or sera obtained from patients infected with other parasite species, specifically and variably recognized up to 20 polypeptides in the molecular mass range of approximately 8 to >80 kDa. There were some differences in the number, intensity, and frequency of recognition of the BE antigens among sera from Venezuelan sites of endemicity with a different status of schistosomiasis transmission. Antigens in the 28- to 24-kDa molecular mass range appeared as immunodominants and were recognized by S. mansoni-positive sera from all the sites, with recognition frequencies varying between 57.5 and 97.5%. Immunoblotting with BE membrane antigens resulted in a highly sensitive (98.1%), specific (96.1.0%), and confirmatory test for the immunodiagnosis of schistosomiasis in low-transmission areas.

Quimioterapia de la esquistosomiasis: antiguos y nuevos fármacos / Chemotherapy of the schistosomiasis; antiques and new medicine

La quimioterapia es utilizada actualmente como la principal estrategia de control de la esquistosomiasis. Antimoniales, tioxantonas, derivados imidazólicos, organofosforados, nitrotiazoles y ditioltionas fueron utilizados por años contra esta parasitosis. La mayoría de esta drogas fueron abandonadas por problemas de toxicidad, efectos neurosíquicos e inmunosupresores, entre otros. En la actualidad, el tratamiento se realiza con praziquantel (PZQ), una pirazinoisoquinolina de amplio espectro , eficaz y capaz de reducir la morbilidad, aunque no de prevenir la reinfección. Por otra parte, las drogas anti-maláricas artemisinina y sus derivados, poseen propiedades anti-esquistosoma con buen perfil de seguridad. El artemeter actúa contra los esquistosómulos y es complementario al PZQ, que actúa sobre los vermes adultos. En la presente revisión, se evalúa la quimioterapia anti-bilharziana y se discuten los mecanismos de acción de las diferentes drogas, incluyendo nuevos posibles blancos de intervención farmacológicas, con el propósito de estimular el desarrollo de alternativas quimioterapéuticas

Péptidos sintéticos para el diagnóstico y vigilancia epidemiológica en esquistosomosis mansoni / Synthetics peptides for the diagnose and vigilance epidemiologic in schitosomiasis mansoni

El diagnóstico de laboratorio de la esquistosomosis es uno de los problemas por resolver, especialmente en áreas de bajas cargas parasitarias, como Venezuela, además de ser también una de las limitantes la evaluación de las nuevas vacunas contra esta parasitosis. Por esta razón, nos planteamos desarrollar métodos de inmunodiagnóstico basados en la detección de anticuerpos y de antígenos circulantes utilizando la estrategia de la síntesis química, para elaborar péptidos derivados de la captesina B (Sm31) y la asparraginil endopeptidasa (Sm32). Tres de los péptidos de la Sm31 fueron reconocidos al menos por el 49 por ciento de los pacientes y de ellos el IMT-180, lo fue por el 86 por ciento, exhibiendo además una alta especificidad (100 por cierto). Dos de los péptidos de la Sm31 y 3 de la Sm32 indujeron en conejos, el reconocimiento de las respectivas moléculas, inclusive en cortes histológicos. Resultados preliminares de inmunoensayos de captura anti-Sm32 han revelado una baja sensibilidad

Evaluación del IEFA como Técnica de inmunodiagnóstico en el programa de lucha contra la bilharziosis / Evaluation of IEFA as inmunodiagnosis technique in the program of struggle againt the schtomiasis

El inmunoensayo para la Fosfatasa Alcalina (IEFA) detecta la presencia de anticuerpos antifosfatasa alcalina de la membrana de los vermes adultos de schistosoma mansoni. Su valor disgnóstico fue probado con 1514 sueros de personas de tres comunidades diferentes del área endémica del interior de Venezuela y 322 sueros de personas del área capitalina de Caracas, encontrandose una sensibilidad de 91,1 por ciento-96,8 por ciento con respecto a la Elisa (con antígenos de huevo). El IEFA fue 100 por cierto específico con sueros de sujetos residentes en localidades no endémicas. Esta metodología mostró menor 84 por cierto de concordancia (Prueba "kappa" de cohen) con "western blot" de antígenos de membrana del adulto y concordancia positiva con la PPCO (40, 6-77,1 por ciento) y la ELISA (51,4-69,1 por ciento) en las poblaciones endémicas estudiadas. Los resultados indican que IEFA es aplicable a la pesquisa epidemiológica de la esquistosomiasis mansoni en zonas endémicas y que la prueba es muy sensible para la detección de casos con baja carga parasitaria (au)